Physician profile
Tan D Tran
NPI 1184642621
$1,143.91
in general payments reported to CMS, 2019-2025
18 companies · $18.25 in 2025
The $18.25 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.28 · 2020: $108 · 2021: $134 · 2022: $304 · 2023: $178 · 2024: $375 · 2025: $18.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $172.60 | 2020-2023 | Shingrix, Bexsero, Arexvy |
| Abbvie INC. | $139.05 | 2023-2024 | Linzess, Viberzi |
| Astrazeneca Pharmaceuticals LP | $136.92 | 2020-2022 | |
| Qol Medical, LLC | $123.70 | 2023-2024 | Sucraid, Sucraid |
| Lilly USA, LLC | $103.52 | 2023-2024 | Jardiance |
| Greenwich Biosciences, INC. | $95.40 | 2020-2021 | |
| Jazz Pharmaceuticals INC. | $76.57 | 2022 | |
| Sunovion Pharmaceuticals INC. | $49.91 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $45.61 | 2019-2021 | |
| Evoke Pharma, INC. | $33.63 | 2024 | |
| Janssen Pharmaceuticals, INC | $29.47 | 2022-2024 | Spravato |
| Eisai INC. | $23.87 | 2022 | |
| Enterra Medical, INC. | $22.46 | 2024 | |
| Sk Life Science, INC. | $21.11 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.52 | 2024 | Dupixent |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $18.25 | 2025 | Gvoke Hypopen |
| Mauna Kea Technologies, INC. | $16.94 | 2024 | |
| Janssen Biotech, INC. | $16.38 | 2024 | Stelara, Simponi, Simponi Aria |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tan Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.